Want to join the conversation?
$PFE said based on Hospira's excellent strategic fit with its Established business and its intense focus on integration of Hospira, it expects to exceed its original synergy targets of $800MM in annual cost savings by 2018. The company added that it now expects to achieve approx. $1Bil in cost savings.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?